Literature DB >> 20529081

From the background to the spotlight: TASK channels in pathological conditions.

Stefan Bittner1, Thomas Budde, Heinz Wiendl, Sven G Meuth.   

Abstract

TWIK-related acid-sensitive potassium channels (TASK1-3) belong to the family of two-pore domain (K(2P) ) potassium channels. Emerging knowledge about an involvement of TASK channels in cancer development, inflammation, ischemia and epilepsy puts the spotlight on a leading role of TASK channels under these conditions. TASK3 has been especially linked to cancer development. The pro-oncogenic potential of TASK3 could be shown in cell lines and in various tumor entities. Pathophysiological hallmarks in solid tumors (e.g. low pH and oxygen deprivation) regulate TASK3 channels. These conditions can also be found in (autoimmune) inflammation. Inhibition of TASK1,2,3 leads to a reduction of T cell effector function. It could be demonstrated that TASK1(-/-) mice are protected from experimental autoimmune inflammation while the same animals display increased infarct volumes after cerebral ischemia. Furthermore, TASK channels have both an anti-epileptic as well as a pro-epileptic potential. The relative contribution of these opposing influences depends on their cell type-specific expression and the conditions of the cellular environment. This indicates that TASK channels are per se neither protective nor detrimental but their functional impact depends on the "pathophysiological" scenario. Based on these findings TASK channels have evolved from "mere background" channels to key modulators in pathophysiological conditions.
© 2010 The Authors; Brain Pathology © 2010 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529081     DOI: 10.1111/j.1750-3639.2010.00407.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  31 in total

1.  Immunocytochemical localization of TASK-3 channels in rat motor neurons.

Authors:  Christiane Marinc; Harald Prüss; Christian Derst; Rüdiger W Veh
Journal:  Cell Mol Neurobiol       Date:  2011-10-20       Impact factor: 5.046

2.  Targeting ion channels for the treatment of autoimmune neuroinflammation.

Authors:  Stefan Bittner; Sven G Meuth
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

Review 3.  Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors:  M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

Review 4.  Much more than a leak: structure and function of K₂p-channels.

Authors:  Vijay Renigunta; Günter Schlichthörl; Jürgen Daut
Journal:  Pflugers Arch       Date:  2015-03-21       Impact factor: 3.657

Review 5.  The two-pore domain potassium channel KCNK5 deteriorates outcome in ischemic neurodegeneration.

Authors:  Eva Göb; Stefan Bittner; Nicole Bobak; Peter Kraft; Kerstin Göbel; Friederike Langhauser; György A Homola; Marc Brede; Thomas Budde; Sven G Meuth; Christoph Kleinschnitz
Journal:  Pflugers Arch       Date:  2014-10-15       Impact factor: 3.657

6.  Differential sensitivity of TREK-1, TREK-2 and TRAAK background potassium channels to the polycationic dye ruthenium red.

Authors:  G Braun; M Lengyel; P Enyedi; G Czirják
Journal:  Br J Pharmacol       Date:  2015-01-08       Impact factor: 8.739

Review 7.  [Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications].

Authors:  S Bittner; K Höhn; K Göbel; C Kleinschnitz; H Wiendl; S G Meuth
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

Review 8.  The CNS under pathophysiologic attack--examining the role of K₂p channels.

Authors:  Petra Ehling; Manuela Cerina; Thomas Budde; Sven G Meuth; Stefan Bittner
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

9.  Two pore domain potassium channels in cerebral ischemia: a focus on K2P9.1 (TASK3, KCNK9).

Authors:  Petra Ehling; Stefan Bittner; Christoph Kleinschnitz; Sven G Meuth; Nicole Bobak; Tobias Schwarz; Heinz Wiendl; Thomas Budde
Journal:  Exp Transl Stroke Med       Date:  2010-07-20

Review 10.  The role of ion channels in malignant brain tumors.

Authors:  Ole J Simon; Thomas Müntefering; Oliver M Grauer; Sven G Meuth
Journal:  J Neurooncol       Date:  2015-09-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.